Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sin, D. D.
Right arrow Articles by Tu, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sin, D. D.
Right arrow Articles by Tu, J. V.
(Chest. 2001;119:720-725.)
© 2001 American College of Chest Physicians

Underuse of Inhaled Steroid Therapy in Elderly Patients With Asthma*

Don D. Sin, MD, MPH and Jack V. Tu, MD, PhD

* From the Department of Medicine (Dr. Tu), Sunnybrook and Women’s College Health Science Center, University of Toronto, Toronto, Ontario; and Department of Medicine (Dr. Sin), University of Alberta, Edmonton, Alberta, Canada.

Correspondence to: Don D. Sin, MD, 2E4.39 Walter C. MacKenzie Center, University of Alberta, Edmonton, Alberta, Canada, T6G 2B7; email: don.sin{at}ualberta.ca

Study objectives: Despite their proven efficacy, inhaled steroids may be underused in the elderly asthmatic population. The objectives of this study were to determine if inhaled steroids are underused in the elderly asthmatic population, who are at a high risk for rehospitalization and mortality, and to identify certain risk factors that predict lower use of inhaled steroids in this group of patients.

Design: Population-based, retrospective, cohort study using linked data from hospital discharge and outpatient drug databases.

Participants: All people >= 65 years old in Ontario, Canada, who survived an acute exacerbation of asthma between April 1992 and March 1997.

Measurements and results: Of the 6,254 patients, 2,495 patients (40%) did not receive inhaled steroid therapy within 90 days of discharge from their initial hospitalization for asthma. Patients > 80 years old were at a greater risk of not receiving inhaled steroid therapy, compared to those 65 to 70 years of age (adjusted odds ratio [OR], 1.23; 95% confidence interval [CI], 1.05 to 1.47). Patients with a Charlson comorbidity index of >= 3 were also at an increased risk of not receiving inhaled steroid therapy, compared to those having no comorbidities (adjusted OR, 3.45; 95% CI, 1.56 to 7.69). Moreover, receipt of care from a primary-care physician was independently associated with an elevated risk of not receiving inhaled steroid therapy, compared to receipt of care from respirologists/allergists (adjusted OR, 1.35; 95% CI, 1.10 to 1.61).

Interpretation: Forty percent of Ontario patients >= 65 years old who experienced a recent acute exacerbation of asthma did not receive inhaled steroid therapy near discharge from their initial hospitalization for asthma. Nonreceipt of inhaled steroid therapy was particularly prominent in the older patients with multiple comorbidities. Moreover, those who received care from primary-care physicians were also less likely to receive inhaled steroid therapy, compared to those who received care from specialists.

Key Words: asthma • comorbidities • elderly • inhaled steroids • underuse




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. C Okafor and J. Thomas III
Presence of Innovation Adoption-Facilitating Elements in Hospitals, and Relationship to Implementation of Clinical Guidelines
Ann. Pharmacother., March 1, 2008; 42(3): 354 - 360.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, October 6, 2003; 327(7418): E46 - 46.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
L. L. Wolfenden, G. B. Diette, J. A. Krishnan, E. A. Skinner, D. M. Steinwachs, and A. W. Wu
Lower Physician Estimate of Underlying Asthma Severity Leads to Undertreatment
Arch Intern Med, January 27, 2003; 163(2): 231 - 236.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. G. Barr, S. C. Somers, F. E. Speizer, and C. A. Camargo Jr
Patient Factors and Medication Guideline Adherence Among Older Women With Asthma
Arch Intern Med, August 12, 2002; 162(15): 1761 - 1768.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. M. Pinto Pereira, Y. Clement, C. K. Da Silva, D. McIntosh, and D. T. Simeon
Understanding and Use of Inhaler Medication by Asthmatics in Specialty Care in Trinidad* : A Study Following Development of Caribbean Guidelines for Asthma Management and Prevention
Chest, June 1, 2002; 121(6): 1833 - 1840.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.